Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Amortization - Intangibles (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Amortization - Intangibles for 2 consecutive years, with $532000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Amortization - Intangibles fell 67.8% to $532000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $4.1 million, a N/A change, with the full-year FY2024 number at $6.1 million, up 27.59% from a year prior.
  • Amortization - Intangibles was $532000.0 for Q3 2025 at Pyxis Oncology, down from $896000.0 in the prior quarter.
  • In the past five years, Amortization - Intangibles ranged from a high of $1.7 million in Q3 2024 to a low of $532000.0 in Q3 2025.